Andere talen Tissue Repair Ltd

Aandelen

TRP

AU0000180887

Beurs gesloten - Australian S.E. Andere beurzen 06:53:18 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,23 ^AUD	0,00%		-4,17%	+4,55%

29/02	Tissue Repair Limited kondigt verandering van bedrijfssecretaris aan	CI
28/02	Tissue Repair Ltd rapporteert resultaten voor het halfjaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tissue Repair Limited Announces Change of Company Secretary	29/02
Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Tissue Repair Secures Third US Patent for Glucoprime Compound	19/12
17,604,240 Options of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 18-NOV-2023.	18/11
13,684,488 Ordinary Shares of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 18-NOV-2023.	18/11
Tissue Repair Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Tissue Repair Limited Announces Company Secretary Changes	28-06-23
Tissue Repair Secures US FDA Clearance for Phase Three Leg Ulcer Trial	29-05-23
Tissue Repair Ltd Appoints Michael Silberberg as Director	02-05-23
Tissue Repair Ltd Announces Board Resignations	26-04-23
Tissue Repair Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	22-02-23
Tissue Repair to Test TR-987 Drug in 2023	29-09-22
Tissue Repair Ltd Announces Change of Company Secretary	28-09-22
Tissue Repair Limited Announces That It Has Received Responses to the Matters Raised in the Type C Meeting That the Company Submitted to the FDA on June 29, 2022	28-09-22
Tissue Repair Secures Second US Patent for Use of Active Ingredient in Skin Conditions	05-09-22
Tissue Repair Limited to Enter a Phase 3 Program in Venous Leg Ulcers	05-09-22
BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)	23-05-22
3,770,440 Ordinary Shares of Tissue Repair Ltd are subject to a Lock-Up Agreement Ending on 30-APR-2022.	30-04-22
Australian Shares Fall Amid Global Selloff as Russia Continues Assault on Ukraine	04-03-22
Tissue Repair Secures US Patent Approval for Wound Drug; Shares Sink 8%	04-03-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Tissue Repair Ltd

Aandelen

TRP

AU0000180887

Andere talen

Filters